Evaluation of the Revogene Carba C assay for detection of carbapenemases in MDR Gram-negative bacteria
- 8 April 2021
- journal article
- letter
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 76 (7) , 1941-1944
Abstract
No abstract availableKeywords
Funding Information
- GenePOC Inc
This publication has 8 references indexed in Scilit:
- Evaluation of the Revogene Carba C Assay for Detection and Differentiation of Carbapenemase-Producing Gram-Negative BacteriaJournal of Clinical Microbiology, 2020
- Carbapenem-Resistant Enterobacterales, Carbapenem Resistant Organisms, Carbapenemase-Producing Enterobacterales, and Carbapenemase-Producing Organisms: Terminology Past its “Sell-By Date” in an Era of New Antibiotics and Regional Carbapenemase EpidemiologyClinical Infectious Diseases, 2020
- Different phenotypic expression of KPC β-lactamase variants and challenges in their detectionJournal of Antimicrobial Chemotherapy, 2019
- Treatment Options for Carbapenem-resistant Gram-negative Bacterial InfectionsClinical Infectious Diseases, 2019
- Rapid and Easy Detection of Carbapenemases in Enterobacterales in the Routine Laboratory Using the New GenePOC Carba/Revogene Carba C AssayJournal of Clinical Microbiology, 2019
- Dissemination and Characteristics of a Novel Plasmid-Encoded Carbapenem-Hydrolyzing Class D β-Lactamase, OXA-436, Found in Isolates from Four Patients at Six Different Hospitals in DenmarkAntimicrobial Agents and Chemotherapy, 2018
- Evaluation of theK-SeT R.E.S.I.S.T. immunochromatographic assay for the rapid detection of KPC and OXA-48-like carbapenemases: Table 1.Journal of Antimicrobial Chemotherapy, 2016
- Evaluation of three commercial assays for rapid detection of genes encoding clinically relevant carbapenemases in cultured bacteriaJournal of Antimicrobial Chemotherapy, 2015